Given its rarity, the prognostic significance of the IRF2BP2::CDX1 gene fusion in myoepithelial tumors of soft tissue is uncertain, with surgical excision being the mainstay of treatment in morphologically low-grade tumors at this point in time. Here, IRF2BP2 is linked to myoepithelial tumor.